Icahn Carl’s Allergan plc AGN Stock Holding History

Icahn Carl’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-425,438	Closed	-$89.3M	–	18
2016 Q4	$89.3M	Hold	425,438	–	–	0.4%	16
2016 Q3	$98M	Sell	425,438 -2,974,562	-87%	-$727M	0.49%	16
2016 Q2	$786M	Buy	+3,400,000	New	+$784M	3.88%	10

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Icahn Carl's AGN Position: Q1 2017 in Review

Icahn Carl sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 425,438 shares — an estimated $89.3M sold.

Icahn Carl first reported a position in AGN in Q2 2016 and held it in 3 quarters. The position peaked at $786M in Q2 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Icahn Carl reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Icahn Carl sold 425,438 Allergan plc shares in Q1 2017, an estimated $89.3M.
Icahn Carl first reported a position in Allergan plc in Q2 2016 and held it in 3 quarters.
Icahn Carl's Allergan plc position peaked at $786M in Q2 2016.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Icahn Carl's 13F filing for Q1 2017, filed 15 May 2017.